Bellecapital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,871
| Closed | -$345K | – | 146 |
|
|
2026
Q1 | $345K | Sell |
2,871
-153
| -5% | -$17.7K | 0.06% | 88 |
|
|
2025
Q4 | $318K | Buy |
3,024
+109
| +4% | +$10.2K | 0.06% | 86 |
|
|
2025
Q3 | $245K | Buy |
2,915
+300
| +11% | +$24.7K | 0.04% | 111 |
|
|
2025
Q2 | $207K | Hold |
2,615
| – | – | 0.04% | 126 |
|
|
2025
Q1 | $235K | Buy |
2,615
+275
| +12% | +$25.7K | 0.05% | 114 |
|
|
2024
Q4 | $233K | Sell |
2,340
-19
| -0.8% | -$1.96K | 0.04% | 128 |
|
|
2024
Q3 | $268K | Buy |
2,359
+19
| +0.8% | +$2.26K | 0.05% | 127 |
|
|
2024
Q2 | $290K | Hold |
2,340
| – | – | 0.06% | 120 |
|
|
2024
Q1 | $309K | Hold |
2,340
| – | – | 0.07% | 126 |
|
|
2023
Q4 | $255K | Sell |
2,340
-91
| -4% | -$9.45K | 0.06% | 133 |
|
|
2023
Q3 | $250K | Sell |
2,431
-369
| -13% | -$39.8K | 0.06% | 143 |
|
|
2023
Q2 | $323K | Sell |
2,800
-690
| -20% | -$78.3K | 0.08% | 129 |
|
|
2023
Q1 | $371K | Hold |
3,490
| – | – | 0.09% | 129 |
|
|
2022
Q4 | $387K | Hold |
3,490
| – | – | 0.11% | 125 |
|
|
2022
Q3 | $301K | Hold |
3,490
| – | – | 0.09% | 138 |
|
|
2022
Q2 | $318K | Hold |
3,490
| – | – | 0.09% | 148 |
|
|
2022
Q1 | $286K | Hold |
3,490
| – | – | 0.09% | 159 |
|
|
2021
Q4 | $267K | Hold |
3,490
| – | – | 0.08% | 164 |
|
|
2021
Q3 | $262K | Hold |
3,490
| – | – | 0.08% | 166 |
|
|
2021
Q2 | $271K | Sell |
3,490
-6,124
| -64% | -$456K | 0.08% | 161 |
|
|
2021
Q1 | $707K | Sell |
9,614
-3,161
| -25% | -$233K | 0.22% | 83 |
|
|
2020
Q4 | $997K | Buy |
12,775
+1,911
| +18% | +$146K | 0.33% | 57 |
|
|
2020
Q3 | $860K | Buy |
10,864
+1,720
| +19% | +$135K | 0.39% | 51 |
|
|
2020
Q2 | $675K | Buy |
9,144
+2,138
| +31% | +$161K | 0.32% | 62 |
|
|
2020
Q1 | $514K | Sell |
7,006
-622
| -8% | -$48.9K | 0.33% | 68 |
|
|
2019
Q4 | $662K | Buy |
7,628
+3,188
| +72% | +$262K | 0.34% | 67 |
|
|
2019
Q3 | $357K | Buy |
4,440
+1,060
| +31% | +$85K | 0.21% | 94 |
|
|
2019
Q2 | $270K | Buy |
3,380
+446
| +15% | +$34.1K | 0.17% | 102 |
|
|
2019
Q1 | $233K | Hold |
2,934
| – | – | 0.15% | 104 |
|
|
2018
Q4 | $214K | Buy |
+2,934
| New | +$207K | 0.15% | 91 |
|
Other funds holding MRK
Bellecapital's MRK Position: Q2 2026 in Review
Bellecapital sold out of Merck (MRK) in Q2 2026, closing a stake of 2,871 shares — an estimated $345K sold.
Bellecapital first reported a position in MRK in Q4 2018 and held it in 30 quarters. The position peaked at $997K in Q4 2020. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Bellecapital reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Bellecapital sold 2,871 Merck shares in Q2 2026, an estimated $345K.
- Bellecapital first reported a position in Merck in Q4 2018 and held it in 30 quarters.
- Bellecapital's Merck position peaked at $997K in Q4 2020.
- 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Bellecapital's 13F filing for Q2 2026, filed 22 Jul 2026.